EVOQ Therapeutics
生物技术研究
Ann Arbor，Michigan 846 位关注者
Developing immunotherapies focused on improving the lives?of individuals fighting autoimmune disease
关于我们
EVOQ Therapeutics is developing immunotherapies to?improve?the lives of individuals fighting autoimmune diseases. There are more than 100?chronic autoimmune diseases - many severely debilitating, and some life-threatening. According to the National Institutes of Health, up to 23.5 million Americans (over 7% of the population) suffer from autoimmune disease, and the prevalence is rising. Autoimmune disease occurs when the body’s central immune tolerance system fails - resulting in T and B cell-mediated destruction of self-tissues. This immune system failure is?responsible for many devastating diseases including – Type 1 Diabetes, Celiac disease, Multiple sclerosis and Rheumatoid Arthritis. EVOQ’s technology unleashes and restores the body’s natural immune tolerance pathways.
- 网站
-
https://www.evoqtherapeutics.com
EVOQ Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Ann Arbor，Michigan
- 类型
- 私人持股
地点
-
主要
获取路线
1600 Huron Parkway
Bldg 420, 2nd Floor
US，Michigan，Ann Arbor，48109